Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients - OncLive
6/16/2022 12:00:00 AM3 years 8 months ago
by Rutgers Cancer Institute of New Jersey
by Rutgers Cancer Institute of New Jersey
Investigators from Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute-Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of druggable oncogenic fusions in colon cancer specimens including…
Investigators from Rutgers Cancer Institute of New Jersey, New Jerseys only National Cancer Institute-Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of drug… [+3398 chars]
full article...